Skip to main content
. 2021 Nov 10;142:106934. doi: 10.1016/j.vph.2021.106934

Fig. 3.

Fig. 3

Association between ACE1 rs1799752 polymorphism and COVID-19 infection as well as ACE1 mRNA levels by rs1799752 genotypes. (a) The results of association tests under five different inheritance models are shown. The Odds Ratios (plus Confidence Intervals) are reported on the X axis in a linear scale. Data on the right of Y axis indicates causative effects toward the risk and the data on the left indicates protective effects. The ACE1 rs1799752 polymorphism was associated with a high risk of COVID-19 in dominant and co-dominant models. In the dominant model, the presence of at least one mutated (−) allele was tested against the homozygous wildtype genotype (wt/wt). The ACE1 rs1799752 polymorphism showed a significant protective effect against COVID-19 risk in over-dominant model. (b) In the total population of patients and controls, different ACE1 mRNA levels were observed among carriers of different rs1799752 genotypes; of note, ID genotype carriers showed a higher expression of ACE1 compared with II genotype carriers (P = 0.01). The level of Odds Ratios was showed as FDR adjusted q-values. MAF: minor allele frequency.